Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intravenous Lidocaine Infusion for Traumatic Rib Fracture Pain Control

NCT03571919 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT03571919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03571919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intravenous Lidocaine Infusion for Traumatic Rib Fracture Pain Control
Lead sponsor
Stanford University
Phase
Phase 4
Overall status
Withdrawn
Start date
June 15, 2018
Completion date
July 1, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, acute, rib fracture multiple, trauma chest